Post-translational modifications contribute to the structure, function, and efficacy of the therapeutic antibody. The extent to which the antibody is modified and the location of the modifications all ...
The engineering and functional characterization of the Fc domain are key to therapeutic antibodies’ efficacy, safety, and pharmacokinetics. The Fc domain is responsible for mediating interactions with ...
- Potential Best-In-Class Bispecific Antibody ATI-052 Targets Both Thymic Stromal Lymphopoietin (TSLP) and Interleukin-4 Receptor (IL-4R) - WAYNE, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Aclaris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback